Literature DB >> 32283014

Neurotrophic Effects of Vascular Endothelial Growth Factor B and Novel Mimetic Peptides on Neurons from the Central Nervous System.

Oksana Dmytriyeva1,2, Amaia de Diego Ajenjo1, Kathrine Lundø1,3, Henrik Hertz4, Kim K Rasmussen1, Anders T Christiansen1, Jorg Klingelhofer1, Alexander L Nielsen5, Jan Hoeber6, Elena Kozlova6, David P D Woldbye1, Stanislava Pankratova1,7.   

Abstract

Vascular endothelial growth factor B (VEGFB) is a pleiotropic trophic factor, which in contrast to the closely related VEGFA is known to have a limited effect on angiogenesis. VEGFB improves survival in various tissues including the nervous system, where the effect was observed mainly for peripheral neurons. The neurotrophic effect of VEGFB on central nervous system neurons has been less investigated. Here we demonstrated that VEGFB promotes neurite outgrowth from primary cerebellar granule, hippocampal, and retinal neurons in vitro. VEGFB protected hippocampal and retinal neurons from both oxidative stress and glutamate-induced neuronal death. The VEGF receptor 1 (VEGFR1) is required for VEGFB-induced neurotrophic and neuroprotective effects. Using a structure-based approach, we designed short peptides, termed Vefin1-7, mimicking the binding interface of VEGFB to VEGFR1. Vefins were analyzed for their secondary structure and binding to VEGF receptors and compared with previously described peptides derived from VEGFA, another ligand of VEGFR1. We show that Vefins have neurotrophic and neuroprotective effects on primary hippocampal, cerebellar granule, and retinal neurons in vitro with potencies comparable to VEGFB. Similar to VEGFB, Vefins were not mitogenic for MCF-7 cancer cells. Furthermore, one of the peptides, Vefin7, even dose-dependently inhibited the proliferation of MCF-7 cells in vitro. Unraveling the neurotrophic and neuroprotective potentials of VEGFB, the only nonangiogenic factor of the VEGF family, is promising for the development of neuroprotective peptide-based therapies.

Entities:  

Keywords:  VEGFB; neurite outgrowth; neuronal survival; peptide

Mesh:

Substances:

Year:  2020        PMID: 32283014     DOI: 10.1021/acschemneuro.9b00685

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  5 in total

1.  Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.

Authors:  Filipa Mota; Tamas Yelland; Jennie A Hutton; Jennifer Parker; Anastasia Patsiarika; A W Edith Chan; Andrew O'Leary; Constantina Fotinou; John F Martin; Ian C Zachary; Snezana Djordjevic; Paul Frankel; David L Selwood
Journal:  Chembiochem       Date:  2021-11-03       Impact factor: 3.164

2.  Sustained delivery of vascular endothelial growth factor mediated by bioactive methacrylic anhydride hydrogel accelerates peripheral nerve regeneration after crush injury.

Authors:  Wanlin Xu; Yifan Wu; Hao Lu; Yun Zhu; Jinhai Ye; Wenjun Yang
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

3.  Mutual stimulatory signaling between human myogenic cells and rat cerebellar neurons.

Authors:  Michal Tamáš; Stanislava Pankratova; Peter Schjerling; Casper Soendenbroe; Ching-Yan Chloé Yeung; Cristian Pablo Pennisi; Jens R Jakobsen; Michael R Krogsgaard; Michael Kjaer; Abigail L Mackey
Journal:  Physiol Rep       Date:  2021-11

4.  Global MicroRNAs Expression Profile Analysis Reveals Possible Regulatory Mechanisms of Brain Injury Induced by Toxoplasma gondii Infection.

Authors:  Zhaofeng Hou; Lele Wang; Dingzeyang Su; Weimin Cai; Yu Zhu; Dandan Liu; Siyang Huang; Jinjun Xu; Zhiming Pan; Jianping Tao
Journal:  Front Neurosci       Date:  2022-03-10       Impact factor: 4.677

5.  Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS.

Authors:  Marcel F Leyton-Jaimes; Patrik Ivert; Jan Hoeber; Yilin Han; Adam Feiler; Chunfang Zhou; Stanislava Pankratova; Varda Shoshan-Barmatz; Adrian Israelson; Elena N Kozlova
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.